[1] Barra F, Grandi G, Tantari M, et al. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments[J]. Expert Opin Biol Ther,2019,19(4):343-360. [2] Matta K, Ploteau S, Coumoul X, et al. Associations between exposure to organochlorine chemicals and endometriosis in experimental studies: A systematic review protocol[J]. Environ Int,2019,124:400-407. [3] Moon J M, Chung Y J, Chae B, et al. Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis[J]. Int J Med Sci,2018,15(13):1530-1536. [4] Chen Z Z, Gong X. Effect of Hua Yu Xiao Zheng decoction on the expression levels of vascular endothelial growth factor and angiopoietin-2 in rats with endometriosis[J]. Exp Ther Med,2017,14(6):5743-5750. [5] Zhang X, Mu L. Association between macrophage migration inhibitory factor in the endometrium and estrogen in endometriosis[J]. Exp Ther Med,2015,10(2):787-791. [6] 李霞,袁航,黄文倩,等. 2018年法国妇产科医师协会/法国国家卫生管理局《子宫内膜异位症管理指南》解读[J]. 中国实用妇科与产科杂志,2018,34(11):1243-1246. [7] 李霞,袁航,黄文倩,等. 2018年法国妇产科医师协会/法国国家卫生管理局《子宫内膜异位症管理指南》解读[J]. 中国实用妇科与产科杂志,2018,34(11):1243-1246. [8] 亓文博,张明乐,黄向华. 腹腔镜保守性手术联合药物治疗中、重度子宫内膜异位症及地诺孕素治疗复发性子宫内膜异位症性盆腔痛的疗效分析[J]. 中华生殖与避孕杂志,2017,37(5):384-388. [9] 杨晓菁,张埃姆. 轻度子宫内膜异位症伴不孕患者应用腹腔镜联合亮丙瑞林治疗的临床效果及对患者生育能力的影响[J]. 中国生化药物杂志,2017,37(9):327-328. [10] 冷金花,戴毅. 子宫内膜异位症治疗新观念[J]. 中华妇产科杂志,2017,52(7):433-435. [11] 郎景和,冷金花,王泽华,等. 促性腺激素释放激素激动剂在子宫内膜异位症和子宫平滑肌瘤治疗中的应用专家意见[J]. 中华妇产科杂志,2017,52(2):77-81. [12] Song J, Wang Y, Yu L. Clinical comparison of mifepristone and gestrinone for laparoscopic endometriosis[J]. Pak J Pharm Sci,2018,31(5(Special)):2197-2201. [13] Xu X R, Wang X, Zhang H, et al. The clinical significance of the combined detection of serum Smac, HE4 and CA125 in endometriosis-associated ovarian cancer[J]. Cancer Biomark,2018,21(2):471-477. [14] 刘瑞. 温经逐瘀汤加减治疗原发性痛经的临床观察[J]. 内蒙古中医药,2013,32(7):44-45. [15] 张莉. 温经逐瘀汤用于子宫内膜异位症治疗中的临床效果[J]. 北方药学,2018,15(12):117-118. [16] 张华军,徐海东,刘婷婷,等. 温经逐瘀汤联合温针灸治疗子宫腺肌症临床研究[J]. 环球中医药,2018,11(3):438-440. [17] Zhang A, Wang G, Jia L, et al. Exosome-mediated microRNA-138 and vascular endothelial growth factor in endometriosis through inflammation and apoptosis via the nuclear factor-kappaB signaling pathway[J]. Int J Mol Med,2019,43(1):358-370. [18] Cao H, Wei Y X, Zhou Q, et al. Inhibitory effect of curcumin in human endometriosis endometrial cells via downregulation of vascular endothelial growth factor[J]. Mol Med Rep,2017,16(4):5611-5617. [19] Vodolazkaia A, Yesilyurt B T, Kyama C M, et al. Vascular endothelial growth factor pathway in endometriosis: genetic variants and plasma biomarkers[J]. Fertil Steril,2016,105(4):988-996. [20] Mahdian S, Aflatoonian R, Yazdi R S, et al. Macrophage migration inhibitory factor as a potential biomarker of endometriosis[J]. Fertil Steril,2015,103(1):153-159.作者简介:杨慧宇(1972.6~),女,汉族,本科,副主任医师,从事子宫内膜异位症的中西医结合治疗。
|